Recent data released by Autoscribe Informatics shows the breadth of industries purchasing a Laboratory Information Management System (LIMS) is moving well beyond what many think of as the core markets of Healthcare, Medical Devices, and Pharmaceuticals.
Such highly regulated industries have been using Laboratory Information Management Systems (LIMS) for many years because it is a requirement to manage their data securely. However, significant growth has recently been seen in other areas including: cannabis testing to keep up with extended use and regulation of cannabis in the leisure and medical industries; environmental testing to meet tighter regulatory requirements, especially in the water and nuclear power industries; food and beverage testing to ensure data from quality control testing is readily available in order to meet increasingly strict FDA audit demands; extended biobank management systems to support ever-growing research into personalised medicine, along with new biotechnology and clinical testing systems to support trials and the roll-out of new treatments.
Other areas with quality control functions are switching from paper systems to LIMS including diverse manufacturing organizsations from paper and materials to chemicals and oil additives. Reducing the burden of managing paper records and the overhead of manually retrieving data across various batches is a key driver, particularly for management reporting and customer audits.
Tim Daniels, Marketing Manager at Autoscribe, said: “We are seeing a broader selection of laboratory types embrace LIMS. Flexibility is the key to meeting this increasing diversity, which is why Matrix Gemini LIMS is so successful. It is a highly configurable solution using a drag-and-drop graphical editor. This allows changes to be made easily to every screen, menu, and list box in the workflow. The result is a LIMS that meets the needs of every laboratory, whilst remaining easy to understand and use.”
Industry analysis that shows the LIMS market is expected to continue its rapid growth, with a CAGR of 13.2% to reach $2.1Bn in 2026. Many new market areas are now switching to LIMS, or indeed upgrading their early LIMS choices to reap the benefits of automation and efficiency in their laboratory. Autoscribe has an extensive range of case studies highlighting laboratories from a broad swathe of industries available here: